Access cutting-edge breast cancer treatment through this clinical trial at a research site in Skokie. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Skokie at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
Researchers are looking for new ways to treat triple-negative breast cancer (TNBC) and hormone receptor (HR) low positive/human epidermal growth factor receptor-2 (HER2) negative breast cancer. The main goals of this study are to learn: * About the safety of the study treatments and if people tolerate them * If people who receive patritumab deruxtecan, pembrolizumab, and chemotherapy before surgery have fewer cancer cells removed during surgery compared to those who receive only pembrolizumab (
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this breast cancer clinical trial in Skokie, IL
If you're searching for breast cancer treatment options in Skokie, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Skokie research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.